The Wharton Moneyball Post Game Podcast


Wharton Moneyball: 2018 Midterm Elections, CFB Stats, & Sports Betting

Ep. 124

In this episode of The Wharton Moneyball Post Game Podcast Cade and Adi host,kicking off the show with midterm election's analytics. Then college football projections with sports analytics writer for the Washington Post. Plus sports betting w/ none other than Cade's partner in crime, Rufus Peabody of Massey-Peabody Analytics. All that and more!


Neil Greenberg is a staff writer with The Washington Post whose beat is sports analytics. His analysis and insight can be found on the Fancy Stats blog, where he covers all pro sports, as well as college football and basketball. He is a member of the Professional Hockey Writers Association and hosts “Crashing the Net” on 106.7 WFAN in Washington, D.C.

Follow on Twitter @ngreenberg 

Michael Salfino is a sports analyst for The Athletic Fantasy Football, The Wall Street Journal, and FiveThirtyEight.

Follow on Twitter @MichaelSalfino

Rufus Peabody is a professional sports bettor. He is also the other half of Massey Peabody Analytics and the Co-host of the Bet The Process pod. He is formerly an ESPN 'predictive analytics expert'.

Follow on Twitter @RufusPeabody

More Episodes


7/22/2020: COVID-19, Sports, David Fajgenbaum

David Fajgenbaum, MD, MBA, MSc is a groundbreaking physician-scientist, disease hunter, and bestselling author of the acclaimed memoir, Chasing My Cure: A Doctor's Race to Turn Hope Into Action. Fajgenbaum went from being a beast-like college Quarterback to receiving his last rites while in medical school and nearly dying four more times battling Castleman disease. To try to save his own life, he spearheaded an innovative approach to research and discovered a possible treatment that has put him into an extended remission. Now, he is spreading this approach to advance cures for other diseases and sharing lessons he learned about living from nearly dying through Chasing My Cure.One of the youngest individuals ever appointed to the faculty at Penn Medicine and the top 1 percent youngest grant awardees of a leading NIH grant, Dr. Fajgenbaum is co-founder and executive director of the Castleman Disease Collaborative Network (CDCN) and Associate Director, Patient Impact, for the Penn Orphan Disease Center. He has been recognized on the Forbes 30 Under 30 list, as a top healthcare leader by Becker's Hospital Review, the Global Genes RARE Champion of Hope: Science awardee, and one of three recipients--including Vice President Joe Biden--of a 2016 Atlas Award from the World Affairs Council of Philadelphia. Before co-founding the CDCN, Dr. Fajgenbaum co-founded and led the Actively Moving Forward Support Network, a non-profit organization dedicated to supporting grieving college students. Dr. Fajgenbaum has been profiled in a cover story by The New York Times as well as by Good Morning America, CNN, and the Today Show, among others.Dr. Fajgenbaum earned a BS from Georgetown University magna cum laude with honors and distinction, MSc from the University of Oxford, MD from the University of Pennsylvania Medical School, and MBA from The Wharton School. He is a former Division I college quarterback, state-champion weight lifter, and co-founder of a national grief support network.